Search For "global pharmaceutical company"
Glenmark Pharma reports revenue growth of 5.6 per cent YoY Q4; 12.4 per ce
Updated : 3 years, 9 months ago IST
Mumbai (Maharashtra) [India], May 30 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the fourth quarter ended March 31, 2022.
Read More
Glenmark launches 'Hello Skin' - India's first Whatsapp based chatbot to h
Updated : 3 years, 9 months ago IST
Mumbai (Maharashtra) [India], May 24 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark), an innovation-led global pharmaceutical company, has developed a digital patient education tool, 'Hello Skin' in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists
Read More
Glenmark receives the 'India Pharma Innovation of the Year' Award from the
Updated : 3 years, 10 months ago IST
Mumbai (Maharashtra) [India], April 27 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global pharmaceutical company, today received the 'India Pharma Innovation of the Year' Award and was adjudged runners-up in the 'India Pharma CSR of the Year' category, a
Read More
Glenmark becomes the First Pharmaceutical Company to launch Teneligliptin
Updated : 3 years, 10 months ago IST
Mumbai (Maharashtra) [India], April 25 (ANI/PR Newswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, with
Read More
Glenmark Specialty S.A. receives approval for conducting Phase 1 Clinical
Updated : 3 years, 11 months ago IST
Mumbai (Maharashtra) [India] April 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, an innovation-driven, global pharmaceutical company, announced that its subsidiary Glenmark Specialty S.A. (Glenmark) received approval from the Indian drug regulator, Drug Controller General of India (
Read More
South Korea approves Pfizer's COVID-19 oral pill for emergency use
Updated : 4 years, 2 months ago IST
Seoul [South Korea], December 28 (ANI/Global Economic): 'Paxlovid,' the COVID-19 oral treatment developed by a global pharmaceutical company Pfizer, received emergency use authorization from the Ministry of Food and Drug Safety (MFDS) on the 27th. It is expected to be used from the end of Ja
Read More
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
Updated : 4 years, 4 months ago IST
Mumbai (Maharashtra) [India], October 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed-dose combination (FDC) of its novel, patent-protected, globally researched Sodium-Glucose Co-Transporter Inhibitor (SGLT2i
Read More
Glenmark Pharmaceuticals launches fixed-drug combination for management of
Updated : 4 years, 4 months ago IST
Mumbai (Maharashtra) [India], October 26 (ANI): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed drug combination for the management of type 2 diabetes.
Read More
Glenmark receives one ANDA approval and two tentative ANDA approvals - Tad
Updated : 5 years, 2 months ago IST
Mumbai (Maharashtra)[India], December 31 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has received final approval by the United States Food & Drug Administration (U.S. FDA) for Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 2
Read More
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
Updated : 5 years, 2 months ago IST
Mumbai (Maharashtra) [India], December 29 . (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed dose combination (FDC) of its novel, patent protected and globally researched Sodium Glucose Co-Transporter Inhibitor (
Read More
Glenmark appoints Dipankar Bhattacharjee to its Board of Directors
Updated : 5 years, 6 months ago IST
Mumbai (Maharashtra) [India], Aug 17 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the appointment of Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization for a period of five years wit
Read More
Glenmark introduces higher strength (400 mg) of FabiFlu® to reduce th
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] Aug 6 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a 400 mg version of oral antiviral FabiFlu®, for the treatment of mild to moderate COVID-19 in India.
Read More